Nurse questionnaire to detect relapse in multiple sclerosis
Part of Brain & nervous system, Immune system & allergy clinical trials.
This study tests a simple questionnaire that a nurse will ask you during regular check-ups to help spot signs of an MS relapse early. The goal is to see if this tool makes it easier for you and your care team to manage your MS and catch problems sooner.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years of age or older.
- You have been diagnosed with relapsing-remitting multiple sclerosis (RRMS) or active secondary progressive multiple sclerosis (active SPMS).
- You are under the care of Dr. Manchon at Centre Hospitalier de Gonesse for your MS.
- You have already agreed to the clinic's task-sharing program (a local setup where nurses take on some tasks from doctors).
- You are not pregnant, and you do not have known kidney failure.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at “subclinical markers,” meaning early or hidden body changes that may show how relapsing-remitting multiple sclerosis (MS) is doing even when symptoms seem mild. It may help researchers find better ways to monitor MS and detect changes sooner.
This study looks at how a failed treatment affects the emotional and social experiences of people with relapsing-remitting MS. If you qualify, you'll be asked to complete questionnaires about your feelings and daily life.
This study looks at whether MS relapses happen without any signs of new disease activity on an MRI scan. By tracking your symptoms and scans, researchers hope to better understand how MS affects people in real life. If you qualify, you may help improve future treatment decisions.
This study follows adults with relapsing-remitting multiple sclerosis using MRI scans and blood tests. It aims to understand how the disease behaves and what markers in blood and imaging may relate to changes over time.
This trial uses MRI scans to monitor spinal cord changes in people newly diagnosed with relapsing-remitting MS who have not yet started treatment. It aims to better understand how the disease progresses and could help guide early treatment decisions.
This study follows people with multiple sclerosis over time to learn more about the disease and improve care. If you join, you will help researchers understand MS better, which could lead to better treatments.
Hear when a new Multiple sclerosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.